The survival benefit of liver transplantation in hepatocellular carcinoma patients

Digestive and Liver Disease

Volumn 42, Issue 9, 2010, Pages 642-649

  Cillo, Umberto ^a   Vitale, Alessandro ^b   Volk, Michael L ^c   Frigo, Anna Chiara ^a   Grigoletto, Francesco ^a   Brolese, Alberto ^a   Zanus, Giacomo ^a   D'Amico, Francesco ^a   Farinati, Fabio ^a   Burra, Patrizia ^a   Russo, Francesco ^a   Angeli, Paolo ^a   D'Amico, Davide F ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Alternative therapies; Hepatocellular carcinoma; Transplant

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HUMAN; LIFE EXPECTANCY; LIVER CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 77955256950     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.02.010     Document Type: Article

References (28)

1. Freeman R.B. The model for end-stage liver disease comes of age. Clin Liver Dis 2007, 11:249-263.
2. Kim W.R., Biggins S.W., Kremers W.K., et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008, 359:1018-1026.
3. Merion R.M., Schaubel D.E., Dykstra D.M., et al. The survival benefit of liver transplantation. Am J Transplant 2005, 5:307-313.
4. Schaubel D.E., Sima C.S., Goodrich N.P., et al. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008, 8:419-425.
5. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
6. Ioannou G.N., Perkins J.D., Carithers R.L. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008, 134:1342-1351.
7. Cillo U., Vitale A., Grigoletto F., et al. Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the Milan criteria. Am J Transplant 2007, 7:972-981.
8. Park J.O., Lee S.I.I., Song S.Y., et al. Measuring response in solid tumors: comparison of RECIST and WHO response criteria. Jpn J Clin Oncol 2003, 33:533-537.
9. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusion of the Barcellona-2000 EASL conference. J Hepatol 2001, 35:421-430.
10. Millonig G., Graziadei I.W., Freund M.C., et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007, 13:272-279.
11. Cillo U., Vitale A., Bassanello M., et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 2004, 239:150-159.
12. UNOS/OPTN policy 3.6.4.4. Available at http://www.optn.org.[accessed 26.02.09].
13. Vitale A., Saracino E., D'Amico F.E., et al. Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis. Transplant Proc 2009, 41:1092-1095.
14. Volk M.L., Vijan S., Marrero J.A. A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant 2008, 8:839-846.
15. Beck J.R., Kassirer J.P., Pauker S.G. A convenient approximation of life expectancy (The " DEALE" ). I. Validation of the method. Am J Med 1982, 73:883-888.
16. Life Tables for Who Member States 2006. Available from: http://www.who.int/whosis/database/life_tables/life_tables.cfm [accessed 20.10.08].
17. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
18. D'Amico G., Garcia-Tsao G., Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006, 44:217-231.
19. Mazzaferro V., Llovet J.M., Miceli R., et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009, 10:35-43.
20. Metroticket calculator web-based software. Available from: [accessed 18.10.08]. http://89.96.76.14/metroticket/calculator/.
21. Onaca N., Davis G.L., Goldstein R.M., et al. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation. Liver Transpl 2007, 13:391-399.
22. Schaubel D.E., Guidinger M.K., Biggins S.W., et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant 2009, 9:970-981.
23. Volk M., Marrero J.A. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed?. Gastroenterology 2008, 134:1612-1614.
24. Volk M., Lok A.S.F., Vijan S. Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation. Med Decis Making 2008, 28:763-772.
25. Majno P.E., Sarasin F.P., Mentha G., et al. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000, 31:899-906.
26. Sarasin F.P., Majno P.E., Llovet J.M., et al. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001, 33:1073-1079.
27. Freeman R.B., Edwards E.B., Harper A.M. Waiting list removal rates among patients with chronic and malignant liver disease. Am J Transpl 2006, 6:1416-1421.
28. Otto G., Herber S., Heise M., et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl 2006, 12:1260-1267.